Clinical Trial Update: Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ilaprazole for gastroesophageal reflux disease in Chinese patients; the study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Ilaprazole (ilaprazole)

Snippet

Sponsor: Livzon Pharmaceutical Group Inc. | Conditions: Gastroesophageal Reflux Disease | Phase 2 | Status: UNKNOWN